Showing results (551-560 of 667) with videos related to

Sort By:
Pageof 67
BMC Cancer|September 21, 2014
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)Margherita Nannini, Annalisa Astolfi, Milena Urbini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 16, 2010
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy numberAnnalisa Astolfi, Margherita Nannini, Maria Abbondanza Pantaleo, et al.
American Journal of Clinical Oncology|December 19, 2009
A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)Wolfram E Samlowski, James Moon, Ralph J Tuthill, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumourAndrew J Wagner, Mark Agulnik, Michael C Heinrich, et al.
Journal of Virology|July 23, 2002
Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cellsAshlee V Moses, Michael A Jarvis, Camilo Raggo, et al.
International Journal of Cancer|August 13, 2009
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic targetMaria A Pantaleo, Annalisa Astolfi, Monica Di Battista, et al.
Annals of the New York Academy of Sciences|January 23, 2003
A functional genomics approach to Kaposi's sarcomaAshlee V Moses, Michael A Jarvis, Camilo Raggo, et al.
Science (New York, N.Y.)|January 11, 2003
PDGFRA activating mutations in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Anette Duensing, et al.
Leukemia|September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)M M Schittenhelm, K W H Yee, J W Tyner, et al.
Journal of Cell Science|March 5, 2010
Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradationSimone Radtke, Stefan Wüller, Xiang-ping Yang, et al.
Pageof 67